Use of Intravenous Immunoglobulin in the Treatment of Immune-Mediated Demyelinating Diseases of the Nervous System. Winkelmann A, Zettl UK Curr Pharm Des. 2012 May 16. PMID: 22612749. Abstract CommentRecommendBookmarkWatch